| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CGP-60474 | GDSC1000 | pan-cancer | AAC | 0.026 | 0.6 |
| mRNA | TPCA-1 | GDSC1000 | pan-cancer | AAC | -0.014 | 0.6 |
| mRNA | Compound 1541A | CTRPv2 | pan-cancer | AAC | 0.02 | 0.6 |
| mRNA | Bosutinib | FIMM | pan-cancer | AAC | -0.23 | 0.6 |
| mRNA | JNJ-26854165 | GDSC1000 | pan-cancer | AAC | -0.017 | 0.6 |
| mRNA | Bortezomib | GDSC1000 | pan-cancer | AAC | 0.024 | 0.6 |
| mRNA | gossypol | CTRPv2 | pan-cancer | AAC | -0.018 | 0.6 |
| mRNA | Teniposide | CTRPv2 | pan-cancer | AAC | -0.019 | 0.6 |
| mRNA | serdemetan | FIMM | pan-cancer | AAC | 0.079 | 0.6 |
| mRNA | GSK525762A | CTRPv2 | pan-cancer | AAC | -0.015 | 0.6 |